Hani Ashamalla

About

Hani Ashamalla is a leading figure in radiation oncology whose research has significantly advanced the treatment of prostate cancer and other malignancies. His work focuses on refining therapeutic strategies to improve patient outcomes, particularly through the integration of stereotactic body radiotherapy (SBRT) and brachytherapy. Ashamalla’s major contributions include challenging established norms in prostate cancer management; his highly cited 2020 study, "Radical Prostatectomy Without Pelvic Lymph Node Dissection Is Widely Practiced in High-Risk Patients Despite Poorer Survival," demonstrated that omitting lymph node dissection in high-risk patients leads to worse survival outcomes, prompting critical re-evaluation of surgical protocols. With over a decade of clinical research, his publications have garnered hundreds of citations, reflecting their influence on practice guidelines. Ashamalla is also recognized for pioneering work in high-dose-rate brachytherapy and for his role in developing multidisciplinary care models. His achievements include numerous institutional awards for clinical excellence and leadership in oncology education, making him a trusted voice in evidence-based cancer care.

Research Focus

Key Achievements

Top Papers

1. 1
   Radical Prostatectomy Without Pelvic Lymph Node Dissection Is Widely Practiced in High-Risk Patients Despite Poorer Survival

   11 citations · 2020

Key Collaborators

Contact & Links